4//SEC Filing
BIO-TECHNE Corp 4
Accession 0001562180-17-002110
$TECHCIK 0000842023operating
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:51 PM ET
Size
10.3 KB
Accession
0001562180-17-002110
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
LUCAS ROGER C
Director
Transactions
- Sale
Common Stock
2017-05-22$110.01/sh−1,059$116,505→ 2,370 total
Holdings
- 4,260
Stock Option (right to buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 3,985
Stock Option (right to buy)
Exercise: $101.19Exp: 2026-10-26→ Common Stock (3,985 underlying) - 4,000
Stock Option (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 4,000
Stock Option (right to buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.05, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeoperating
IncorporatedMN
Related Parties
1- filerCIK 0000842023
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 4:51 PM ET
- Size
- 10.3 KB